drugset / Trial / NCT01991145
Allogeneic UCB Therapy With EPO in Children With CP
Completed
92 enrolled
MinYoung Kim, MD, PhD
CHA University · collabChong Kun Dang Pharmaceutical · collabLG Life Sciences · collabMinistry of Health & Welfare, Korea · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This randomized controlled study aims to evaluate the efficacy and safety of allogeneic umbilical cord blood therapy combined with erythropoietin for children with cerebral palsy.
Timeline
- Start
- 2013-11-26
- Primary completion
- 2017-06-24
- Completion
- 2017-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 500 iu/kg | — |